
SeaStar Medical Holding Corporation
ICUHealthcare|Biotechnology|US
$1.88
-0.04 (-2.08%)
DCF Value
$3.08
Tangible Book / Share
$1.05
Cash / Share
$1.70
Next Earnings Report
Nov 11, 2026
EPS est. -$0.95 · Revenue est. $500.0K
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Oct 30, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (2)
Dec 2026
Est. completion
NAAcute Kidney Injury
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NCT05758077n=339
Feb 2027
Est. completion
NAAcute on Chronic Systolic Congestive Heart Failure
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
NCT03836482n=20
Recent Press Releases
ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
Nov 6, 2026 · GlobeNewsWire
SeaStar Medical to Report Third Quarter Financial Results on November 11, 2026
Nov 4, 2026 · GlobeNewsWire
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
Nov 3, 2026 · GlobeNewsWire
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
Oct 22, 2026 · GlobeNewsWire
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
Oct 22, 2026 · GlobeNewsWire
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
Oct 14, 2026 · GlobeNewsWire
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
Oct 7, 2026 · GlobeNewsWire
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
Oct 5, 2026 · GlobeNewsWire
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
Oct 2, 2026 · GlobeNewsWire
SEC Filings (105)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Oct 30, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 8, 2026 | D | DocumentIndex | |
| Oct 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jul 21, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jul 1, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K/A | Material event | DocumentIndex |
| Jun 17, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | EFFECT | DocumentIndex | |
| May 11, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 7, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| May 5, 2026 | EFFECT | DocumentIndex | |
| May 5, 2026 | EFFECT | DocumentIndex | |
| May 5, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2026 | POS AM | DocumentIndex | |
| Apr 28, 2026 | POS AM | DocumentIndex | |
| Apr 28, 2026 | POS AM | DocumentIndex | |
| Apr 28, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Apr 28, 2026 | 8-K | Material event | DocumentIndex |
| Mar 25, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 25, 2026 | 8-K | Material event | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 20, 2026 | 8-K | Material event | DocumentIndex |
| Dec 23, 2025 | 8-K/A | Material event | DocumentIndex |
| Dec 18, 2025 | 8-K | Material event | DocumentIndex |
| Nov 20, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 4, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 14, 2025 | 424B5 | Offering prospectus | DocumentIndex |